BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ameku K, Higa M. Rivaroxaban Treatment for Warfarin-Refractory Thrombosis in a Patient with Hereditary Protein S Deficiency. Case Rep Hematol 2018;2018:5217301. [PMID: 29607227 DOI: 10.1155/2018/5217301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ohashi I, Wada S, Yoshino F, Kuwashiro T, Matsumoto S, Hotta T, Kang D, Okada Y, Shimohama S, Yasaka M. Ischemic Stroke with Protein S Deficiency Treated by Apixaban. J Stroke Cerebrovasc Dis 2020;29:104608. [PMID: 31941580 DOI: 10.1016/j.jstrokecerebrovasdis.2019.104608] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Nair PM, Rendo MJ, Reddoch-Cardenas KM, Burris JK, Meledeo MA, Cap AP. Recent advances in use of fresh frozen plasma, cryoprecipitate, immunoglobulins, and clotting factors for transfusion support in patients with hematologic disease. Semin Hematol 2020;57:73-82. [PMID: 32892846 DOI: 10.1053/j.seminhematol.2020.07.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Naghavi S, Pourmohammadi A, Adibi I. Rivaroxaban in Recurrent Ischemic Stroke Due to Protein S Deficiency: A Case Report. Neurol Ther 2021;10:401-6. [PMID: 33517536 DOI: 10.1007/s40120-021-00232-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lounici A, Bensefia A, Tabti E, Bestaoui M. A descriptive monocentric study in Algeria of adults with cerebral venous thrombosis. Revue Neurologique 2020;176:614-8. [DOI: 10.1016/j.neurol.2020.02.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Khider L, Gendron N, Mauge L. Inherited Thrombophilia in the Era of Direct Oral Anticoagulants. IJMS 2022;23:1821. [DOI: 10.3390/ijms23031821] [Reference Citation Analysis]